Calunsag, Primitiva B.
HRN: 12-35-20 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/22/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
08/22/2022
08/28/2022
IVT
4.5g
Q6
Cap Mr
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: No Wrong Choice Follow NAG Recommended Antibiotic
Final appropriateness: No Wrong Choice Wrong Choice
Overall appropriateness: No Wrong Choice